摘要
目的:探讨小剂量普萘洛尔口服治疗婴儿血管瘤的疗效与安全性。方法:选取150例血管瘤患儿为观察组,采用小剂量普萘洛尔进行治疗;选取同期接受尿素局部注射治疗的50例婴儿血管瘤患者为对照组。比较两组治疗效果及预后效果。结果:观察组总有效146例(97.3%),对照组为36例(72.0%),两者差异比较具有统计学意义(P<0.05);两组预后效果比较基本无差异,无统计学意义(P>0.05)。结论:小剂量普萘洛尔应用于婴幼儿血管瘤临床治疗,效果肯定,不良反应可耐受,具推广意义。
Objective.. To evaluate the efficacy and safety of propranolol in the treatment of infantile hemangiomas. Methods ： Choose 150 cases of hemangioma patients as observation group, with low-dose propranolol treatment~ select 50 cases of hemangioma patients as control group with local injections of urea treatment. Compare two groups of treatment effect and prognosis effect. Results ： 146 cases （97.3%） are effective in observation group, while 36 cases （72.0%） in the control group, the difference is statistically significant （P〈0.05）; prognostic effect is no difference between the two groups, no statistical significance （P〉0.05）. Conclusion ：propranolol treatment at a low dose is a safe and effective regi- men for infantile hemangiomas, the efficacy is excellent while the side effects are minimal, it has clinical significance.
出处
《黄冈师范学院学报》
2015年第6期42-44,共3页
Journal of Huanggang Normal University
关键词
普萘洛尔
婴儿血管瘤
安全性
propranolol
infantile hemangiomas
security
